Excellent Long-Term Survival and Immune Recovery With Reduced-Intensity Conditioning HCT in Inborn Errors of Immunity
- 6 May 2026
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (9) , 1125.e1-1125.e15
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohortJournal of Allergy and Clinical Immunology, 2022
- Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency DiseasesJournal of Clinical Immunology, 2021
- Conditioning Regimens for Hematopoietic Cell Transplantation in Primary ImmunodeficiencyCurrent Allergy and Asthma Reports, 2019
- Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined ImmunodeficiencyTransplantation and Cellular Therapy, 2019
- Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC studyJournal of Allergy and Clinical Immunology, 2019
- One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 yearsJournal of Allergy and Clinical Immunology, 2018
- Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK ExperienceTransplantation and Cellular Therapy, 2018
- Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantationJournal of Allergy and Clinical Immunology, 2017
- Single Daily Busulfan Dosing for Infants with Nonmalignant Diseases Undergoing Reduced-Intensity Conditioning for Allogeneic Hematopoietic Progenitor Cell TransplantationTransplantation and Cellular Therapy, 2015
- Reduced-Intensity Conditioning Hematopoietic Cell Transplantation Is an Effective Treatment for Patients with SLAM-Associated Protein Deficiency/X-linked Lymphoproliferative Disease Type 1Transplantation and Cellular Therapy, 2014